Rising Consumption of Fast, Junk, and Unhealthy Food and Beverage Items is one of the Major Factors Fostering the Growth of the Weight Loss and Obesity Management Market

 

The prevalence rate of obesity around the globe varies as per gender, age, geographical location, socio-economic conditions, and other factors. As per the data for 2021, 13% of the world population falls in the category of obesity or obese. In 2017, 8% of the total deaths recorded resulted from obesity. Obesity has emerged as one of the leading factors for premature deaths globally.  

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-weight-loss-and-obesity-management-market

The global weight loss and obesity management market is expected to reach USD 13,140.12 million by 2029 from USD 8,558.00 million in 2021, growing at a CAGR of 5.5% in the forecast period of 2022 to 2029. The rising geriatric population base globally and lack of awareness among them in maintaining good health and fitness promote obesity and overweight phenomenon, and this will create a great scope of growth for the weight loss and obesity management market.

Weight Loss and Obesity Management Market

The increasing prevalence rate of chronic diseases is expected to drive the market's growth rate

Rising incidence rate of chronic diseases such as gall bladder disease, cancer, insulin resistance, high blood pressure, atherosclerosis, stroke, thyroid, cardiovascular disease, polycystic ovarian syndrome, type 2 diabetes act as major market growth determinants for weight loss and obesity management market. According to the world health organization, in 2019, around 17.9 million people died from cardiovascular diseases, representing 32% of all global deaths. 39% of the world's population is overweight.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2020

Historic Years

2019 (Customizable to 2018 - 2013)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Diet (Dietary Supplements, Meals, Beverages), Equipment (Fitness Equipment, Cardiovascular Training Equipment, Strength Training Equipment, Fitness Monitoring Equipment, Body Composition Analyzers, Surgical Equipment, Minimally Invasive Surgical Equipment, Noninvasive Surgical Equipment), Service (Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss Programs), Form (Soft Gels, Tablets, Capsule, Powders, Gummies and Jellies, Premixes, Liquids, Others), Nature (Conventional, Clean Labelled), Category (Prescribed, Over The Counter (OTC)), End User Demography (Under 18 Years, 18 To 35 Years, 35 To 50 Years, Above 50 Years), Distribution Channel (Store Based, Non-Stored Based)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Atkins Global (U.S.), Herbalife International of America Inc., (U.S.), Nutrisystem Inc., (U.S.), Abbott (U.S.), Kellogg;s Company (U.S.), mega Laboratories, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Medtronic (U.S.), Apollo Endosurgery Inc., (U.S.),  GlaxoSmithKline plc (U.K), Olympus (Japan), WW International Inc., (U.S.), Jenny Craig (U.S.),   Gold's Gym  (U.S.), DSM (Netherlands), Brunswick  (U.S.), Amer Sports (Finland), Johnson Health Tech (Taiwan), Technogym SpA (Italy), Shaklee Corporation (U.S.), Nature's Sunshine Products, Inc., (U.S.) and Novo Nordisk A/S (Denmark) among others            

Data Points Covered in the Report

The market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The weight loss and obesity management market is segmented on the basis of product type, product form, nature, category, end user, and distribution channel.

  • On the basis of product type, the global weight loss and obesity management market is segmented into dietary supplements and meal replacements. In 2022, dietary supplements segment is expected to dominate the weight loss and obesity management market with a 77.91% market share due to increasing obese population, rising consumer awareness regarding low-calorie food and beverages in developing economies.

Dietary supplements is expected to dominate product type segment of the weight loss and obesity management market in 2022

Dietary supplements are easily available via online and offline modes of distribution. However, these must be consumed only after considering the suggestions of physician, doctor and healthcare provider. Over-dosage of dietary supplements can lead to numerous side effects. Owing to the easy availability of dietary supplements, the segment is expected to dominate in 2022.

  • On the basis of product form, the global weight loss and obesity management market is segmented into the soft gels, tablets, capsule, powders, gummies & jellies, premixes, liquids, and others. In 2022, Powders segment is expected to dominate the weight loss and obesity management market with a 29.52% market share due to easy to use nature of powder form as compared to other forms of weight loss and obesity management.
  • On the basis of nature, the global weight loss and obesity management market is segmented into the conventional and clean labelled. In 2022, conventional segment is expected to dominate the weight loss and obesity management market with a 74.09% market share due to growing demand for organic, naturally grown products.
  • On the basis of category, the global weight loss and obesity management market is segmented into prescribed and over the counter (OTC). In 2022, over the counter (OTC) segment is expected to dominate the weight loss and obesity management market with a 76.00% market share due to growing popularity of OTCs for weight loss and obesity management.
  • On the basis of end user, the global weight loss and obesity management market is segmented into under 18 years, 18 to 35 years, 35 to 50 years, and above 50 years. In 2022, 18 To 35 years segment is expected to dominate the weight loss and obesity management market with a 45.81% market share due to rise in the rate of childhood obesity.

18 To 35 years is expected to dominate the end user segment of the weight loss and obesity management market

The age bracket of 18-35 years is the most active as this category includes students, workers, corporate staff and youngsters especially. Rising awareness among the people in this age bracket in regards to maintaining health and fitness is bolstering the growth of the segment. Moreover, increased exposure to social media platforms too acts as an indirect determinant.

  • On the basis of distribution channel, the global weight loss and obesity management market is segmented into the store based and non-stored based. In 2022, store based segment is expected to dominate the weight loss and obesity management market with a 69.01% market share due to emerging COVID-19 pandemic.

Major Players

Data Bridge Market Research recognizes the following companies as the major weight loss and obesity management market players in advanced wound care market are Marcel Carrageenan (Phillipines), Maine Coast Sea Vegetables (U.S.), Ocean Rainforest (U.S.), Irish Seaweeds (U.K.), Aushadh Limited (India), Wild Irish Seaweeds (Ireland).

Weight Loss and Obesity Management Market

Market Development-

  • In January 2020, FDA announce that they are conducting a nationwide recall of all lots of its dietary supplement products pursuant to a Consent Decree entered by the U.S. District Court for the Eastern District of New York for the ABH PHARMA, INC., company and others. This recall applies to all dietary supplement products manufactured and sold between January 2013 – November 2019 and all lots of products are included in this recall.
  • In December 7, 2021, FDA asked Western Herb Products, Inc. to recall their dietary supplements following an inspection of the company's manufacturing facility in Washington, which found the company's products to be adulterated because they were prepared, packed, or held in conditions that do not meet Current Good Manufacturing Practice (cGMP) for dietary supplements. The United States Food and Drug Administration (FDA) reviewed dietary enhancement manufacturing facility. During the review, FDA recognized infringement of Title 21, Code of Federal Regulations (CFR), Part 111 (21 CFR Part 111), Current Good Manufacturing Practice (CGMP) in manufacturing, packaging, labeling, or holding operations for dietary supplements.
  • In April 2020, NutriZone, LLC of Houston, Texas announced its recall of various kratom dietary supplements to all lots sold, which may contain the same source material as the original recalled lots. This recall action by NutriZone, LLC is aimed to regulate the production and sales of the dietary supplements.
  • In October 2020, Vitaco Health announced to increase their distribution network by starting the manufacturing of Distribution Centre at 11 Kordel Place with the increasing demand for supplementary products. 

Regional Analysis

Geographically, the countries covered in the weight loss and obesity management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in weight loss and obesity management market during the forecast period 2022 -2029

In 2022, North America is will hold the biggest market size in weight reduction and weight management market during the forecast period. Factors, for example, the rising occurrence of heftiness and ongoing illnesses, rising mindfulness about nourishment and sound ways of life, developing number of wellness focuses, and rising disposable income are the central factors supporting the development of the weight loss and weight management market.. 

Asia-Pacific is estimated to be the fastest growing region in weight loss and obesity management market the forecast period 2022 -2029

Asia-Pacific is expected to grow during the forecast period due to the presence of major market players and rapid development of medical facilities in emerging economies in this region. In addition to this, rising level of healthcare expenditure and increasing per-capita income are expected propel the market's growth rate in this region.

COVID-19 Impact Analysis

The weight loss and obesity management market was generally influenced by the episode of COVID-19. The inconvenience of the lockdown and social distancing limitations during COVID-19 episode pandemic, prompted store network disturbances, smothering business development, innovation events retractions, suspensions of new technological developments and has impacted the general manufacturing industry. Besides, the application of robotic innovations are presently being utilized in modern operations to lessen employee thickness. Likewise, the producers are zeroing in on different turns of events and developments, market patterns and other extension techniques which will speed up the development of the market.

Also, there has been a decline in COVID-19 patients worldwide, which will result in increased health care services. Moreover, the restrictions and measures are likely to relax, which will help market to witness a slight increment, as the manufacturers are focusing on various developments and innovations, market trends, and other expansion strategies.

For more detailed information about the weight loss and obesity management market report, click here – https://www.databridgemarketresearch.com/reports/global-weight-loss-and-obesity-management-market